SCHEMBL7350978

SCHEMBL7350978

COc1ccc(S(=O)(=O)N(Cc2ccccc2)C2CCC(NCC(=O)OCc3ccccc3)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 1/20 0.54
▸ MMP1 P03956 3/20 0.54
▸ MMP9 P14780 3/20 0.54
▸ MMP13 P45452 3/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ CNR1 P21554 1/20 0.48
▸ CNR2 P34972 1/20 0.48
▸ CXCR3 P49682 3/20 0.47
▸ TAS2R14 Q9NYV8 2/20 0.47
▸ PTGES O14684 1/20 0.46
▸ TAS2R8 Q9NYW2 1/20 0.46
▸ TSHR P16473 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ BMP1 P13497 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7347672 0.92 KCNA5 (0.58) KCNA5MMP1MMP9MMP13L3MBTL1
SCHEMBL7351711 0.81 KCNA5 (0.53) KCNA5MMP1MMP9MMP13L3MBTL1
SCHEMBL8015046 0.79 KCNA5 (0.56) KCNA5MMP1MMP9MMP13L3MBTL1
SCHEMBL7615370 0.78 MMP1 (0.70) KCNA5MMP1MMP9MMP13L3MBTL1
SCHEMBL7419400 0.78 KCNA5 (0.48) KCNA5MMP1MMP9MMP13L3MBTL1
SCHEMBL7423956 0.78 KCNA5 (0.49) KCNA5MMP1MMP9MMP13CNR1
SCHEMBL7423616 0.77 KCNA5 (0.46) KCNA5MMP1MMP9MMP13CNR1
SCHEMBL7422208 0.77 KCNA5 (0.46) KCNA5MMP1MMP9MMP13CNR1
SCHEMBL7421563 0.76 KEAP1 (0.48) KCNA5MMP1MMP9MMP13CNR1
Hydrochloric Acid SCHEMBL7355764 0.74 KCNA5 (0.50) KCNA5MMP1MMP9MMP13CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0766672-B1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS NOVARTIS AG (CH) 2000-10-04 — — EP disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 — — US disclosed
EP-0766672-A1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS Novartis AG (CH) 1997-04-09 — — EP disclosed
US-5506242-A METALLOELASTASE INHIBITOR; TREATS EMPHYSEMA CIBA-GEIGY CORPORATION (US) 1996-04-09 — — US disclosed
WO-1996000214-A1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS CIBA-GEIGY AG (CH) 1996-01-04 — — WO disclosed
Send feedback